Literature DB >> 24748137

The great masquerader: Behcet's disease.

Edra Nordstrom1, Monika Fischer.   

Abstract

This report describes the case of a 44-year-old Caucasian woman of Northern European descent with a medical history of pyoderma gangrenosum, chronic abdominal pain and erythema nodosum which required intermittent use of high-dose steroids that failed to improve her symptoms. The patient was initially diagnosed with Crohn's disease and most recently with sclerosing mesenteritis. She presented to the hospital with worsening abdominal pain. She was found to have recurrent painful aphthous oral, genital and perianal ulcers and a clinical diagnosis of Behçet's disease was made. Her hospitalisation was complicated by haemoptysis, and bronchoscopy revealed alveolar haemorrhage. Treatment was initiated with three days of pulse intravenous solumedrol 1 g/day and cyclophosphamide at 700 mg/m(2). The case had a favourable outcome despite the initial diagnostic challenges. This report emphasises that systemic diseases, including Behçet's disease, can have variable presentations and can be frequently misdiagnosed.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24748137      PMCID: PMC3992552          DOI: 10.1136/bcr-2013-202919

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  14 in total

Review 1.  Behçet's disease: infectious aetiology, new autoantigens, and HLA-B51.

Authors:  H Direskeneli
Journal:  Ann Rheum Dis       Date:  2001-11       Impact factor: 19.103

Review 2.  Behçet's disease and genes within the major histocompatibility complex region.

Authors:  Yeong Wook Song; Eun Ha Kang
Journal:  Mod Rheumatol       Date:  2011-10-25       Impact factor: 3.023

3.  EULAR recommendations for the management of Behçet disease.

Authors:  G Hatemi; A Silman; D Bang; B Bodaghi; A M Chamberlain; A Gul; M H Houman; I Kötter; I Olivieri; C Salvarani; P P Sfikakis; A Siva; M R Stanford; N Stübiger; S Yurdakul; H Yazici
Journal:  Ann Rheum Dis       Date:  2008-01-31       Impact factor: 19.103

4.  Clinical Studies on Behçet's Syndrome.

Authors:  Y Oshima; T Shimizu; R Yokohari; T Matsumoto; K Kano; T Kagami; H Nagaya
Journal:  Ann Rheum Dis       Date:  1963-01       Impact factor: 19.103

5.  Granulomatous endocarditis with systemic embolism in Behçet's disease.

Authors:  E C Huycke; M Robinowitz; I S Cohen; N A Burton; S M Fall; E Boling; D Hough
Journal:  Ann Intern Med       Date:  1985-06       Impact factor: 25.391

6.  Thalidomide in the treatment of the mucocutaneous lesions of the Behçet syndrome. A randomized, double-blind, placebo-controlled trial.

Authors:  V Hamuryudan; C Mat; S Saip; Y Ozyazgan; A Siva; S Yurdakul; K Zwingenberger; H Yazici
Journal:  Ann Intern Med       Date:  1998-03-15       Impact factor: 25.391

7.  Short-term trial of etanercept in Behçet's disease: a double blind, placebo controlled study.

Authors:  Melike Melikoglu; Izzet Fresko; Cem Mat; Yilmaz Ozyazgan; Feride Gogus; Sebahattin Yurdakul; Vedat Hamuryudan; Hasan Yazici
Journal:  J Rheumatol       Date:  2005-01       Impact factor: 4.666

8.  Interferon alfa-2a in the treatment of Behçet disease: a randomized placebo-controlled and double-blind study.

Authors:  Erkan Alpsoy; Cicek Durusoy; Ertan Yilmaz; Yilmaz Ozgurel; Oya Ermis; Sahin Yazar; Erdal Basaran
Journal:  Arch Dermatol       Date:  2002-04

9.  The International Criteria for Behçet's Disease (ICBD): a collaborative study of 27 countries on the sensitivity and specificity of the new criteria.

Authors: 
Journal:  J Eur Acad Dermatol Venereol       Date:  2013-02-26       Impact factor: 6.166

10.  Characterisation of the local inflammatory response in appendicitis.

Authors:  M Tsuji; P Puri; D J Reen
Journal:  J Pediatr Gastroenterol Nutr       Date:  1993-01       Impact factor: 2.839

View more
  1 in total

Review 1.  Small Bowel Lesions Mimicking Crohn's Disease.

Authors:  David B Sachar
Journal:  Curr Gastroenterol Rep       Date:  2018-08-06
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.